Seeing Is Believing
Currently out of the existing stock ratings of Lyanne Harrison, 3 are a SELL (33.33%), 1 are a HOLD (11.11%), 5 are a BUY (55.56%).
Analyst Lyanne Harrison, currently employed at BAML, carries an average stock price target met ratio of 37.5% that have a potential upside of 15.46% achieved within 56 days.
Lyanne Harrison’s has documented 18 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RMD, ResMed at 17-Oct-2023.
Analyst best performing recommendations are on RMD (RESMED).
The best stock recommendation documented was for RMD (RESMED) at 8/3/2020. The price target of $180 was fulfilled within 3 days with a profit of $15.4 (7.88%) receiving and performance score of 26.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
236
$-9.02 (-3.68%)
236
29 days ago
10/10 (100%)
$12.36 (5.53%)
230
Hold
200
2 months 6 days ago
7/12 (58.33%)
$-17.58 (-8.08%)
84
Buy
215
$-30.02 (-12.25%)
215
5 months 4 days ago
9/11 (81.82%)
$19.11 (9.76%)
65
164
$-81.02 (-33.07%)
158
7 months 6 days ago
5/6 (83.33%)
$-21.47 (-11.58%)
162
Buy
207
$-38.02 (-15.52%)
7 months 6 days ago
5/5 (100%)
$21.53 (11.61%)
67
What Year was the first public recommendation made by Lyanne Harrison?